Structure Therapeutics GPCR
NASDAQ GPCR
$47.34 +0.00 (+0.00%)
As of: Sep 4, 2026 · 3:59 PM EDT

Structure Therapeutics (GPCR) Amortizatization of Intangibles (2023 - 2026)

Structure Therapeutics (GPCR) posted quarterly Amortizatization of Intangibles of $10000.0 for Q1 2026, down 96.89% quarter-over-quarter from $322000.0 in Q4 2025.

Analysis

Structure Therapeutics (GPCR) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends

Structure Therapeutics' Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at $10000.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles changed N/A year-over-year to $10000.0; the TTM figure through Mar 2026 stood at $342000.0 (changed N/A YoY), while the FY2025 annual figure was $345000.0, up 8525.0% from the prior year.
  • Amortizatization of Intangibles for Q1 2026 stood at $10000.0, down from $322000.0 in the prior quarter.
  • The five-year high for Amortizatization of Intangibles was $322000.0 in Q4 2025, with the low at -$7000.0 in Q4 2024.
  • The 4-year median for Amortizatization of Intangibles is $13500.0 (2023), against an average of $85500.0.
  • The sharpest annual moves came in 2024 and 2025: Amortizatization of Intangibles plunged 141.18% in 2024, then surged 4700.0% in 2025.
  • Structure Therapeutics' Amortizatization of Intangibles stood at $17000.0 in 2023, then sank by 141.18% to -$7000.0 in 2024, then soared by 4700.0% to $322000.0 in 2025, then slumped by 96.89% to $10000.0 in 2026.
  • Business Quant data shows GPCR's Amortizatization of Intangibles at $10000.0 in Q1 2026, $322000.0 in Q4 2025, and -$7000.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - 4.33 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 678,000.00
10 Structure Therapeutics 10.32 Bn 10.32 Bn - 19,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19,000.00
Mar 31, 2026 10,000.00
Dec 31, 2025 322,000.00
Dec 31, 2024 -7,000.00
Dec 31, 2023 17,000.00